Cytokinetics, Incorporated
CYTK
Rang in aandelen
#2258
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on... Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Aandeelprijs
$64.11
Marktkapitalisatie
$8.91B
Verandering (1 dag)
2.34%
Verandering (1 jaar)
8.03%
Land
US
Handel Cytokinetics, Incorporated (CYTK)
Categorie
Healthcare
Aandelsplitsingen voor Cytokinetics, Incorporated (CYTK)
Het aandeel Cytokinetics, Incorporated (symbool: CYTK) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Jun 25, 2013.
Eén aandeel CYTK dat vóór Jun 25, 2013 werd gekocht, staat nu gelijk aan 0.16666666666667 aandelen CYTK.
De meest recente splitsing vond plaats op Jun 25, 2013.
Eén aandeel CYTK dat vóór Jun 25, 2013 werd gekocht, staat nu gelijk aan 0.16666666666667 aandelen CYTK.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2013-06-25 | 1:6 | x0.16666666666667 | x0.16666666666667 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
